Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
NRC
NTLA
Add up to 3 more stocks
NRC
NRC Health
-4.55%
$20.35-0.97Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$458.62M
52W Range
$11.01 - $23.68
NTLA
Intellia Therapeutics, Inc.
+1.16%
$12.26+0.14Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$1.71B
52W Range
$7.95 - $28.25
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 80.63 | N/A |
| Forward P/E | 23.13 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 70.03 | 2.35 |
| P/S Ratio | 3.28 | 28.79 |
| P/FCF Ratio | 21.19 | N/A |
| EV/EBITDA | 23.34 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 56.3% | 76.5% |
| Operating Margin | 10.5% | -651.7% |
| Net Margin | 4.2% | -672.2% |
| ROE | 89.4% | -55.0% |
| ROA | 4.3% | -46.7% |
| ROIC | 8.8% | -54.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.65 | 6.65 |
| Quick Ratio | 0.65 | 6.65 |
| Debt/Equity | 13.75 | 0.10 |
| Interest Coverage | 4.74 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 2.8% | N/A |
| Payout Ratio | 237.7% | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.